Loading...
Acute pancreatitis in the use of canagliflozin: A rare side-effect of the novel therapy for type 2 diabetes mellitus
Canagliflozin (Invokana) is an innovative treatment for type 2 diabetes mellitus (DM) approved in a new class acknowledged as sodium-glucose co-transporter 2 inhibitors. Acute pancreatitis is a very rare side effect with an incidence <1%. a 50-year-old white male with DM type 2 presented to the e...
Na minha lista:
| Udgivet i: | J Basic Clin Pharm |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Medknow Publications & Media Pvt Ltd
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4513334/ https://ncbi.nlm.nih.gov/pubmed/26229348 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-0105.160753 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|